查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1392035

脑下垂体癌市场：依癌症类型、荷尔蒙类型、治疗类型、年龄层、最终使用者、地区

Pituitary Cancer Market, By Cancer Type, By Hormone Type, By Treatment Type, By Age Group, By End User, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3个工作天内

价格
简介目录

据估计，2023年全球脑下垂体癌市场规模为3.807亿美元，2030年达7.233亿美元，在预测期内（2023-2030年）复合年增长率为9.6%。

报告范围 报告详情
基准年 2022年 2023年市场规模 3.807 亿美元
实绩资料 2018-2021 预测期 2023-2030
预测期复合年增长率 9.60% 2030年市场规模预测 7.233 亿美元
图 1. 2023 年按地区分類的脑下垂体癌全球市场占有率(%)
脑下垂体癌市场-IMG1

脑下垂体癌的病因尚不清楚。然而，遗传和荷尔蒙失衡可能发挥了作用。大多数脑下垂体肿瘤是腺瘤，这意味着它们是非癌性的。脑下垂体癌比脑下垂体囊肿少见，脑下垂体囊肿是良性的（非癌性的）。

脑下垂体癌的症状通常包括头痛、视力改变、体重减轻或无法增加体重、记忆力或註意力不集中。根据脑下垂体瘤的类型，可能会分泌过量的激素，导致库欣氏症候群。这种疾病会导致催乳素分泌过多，导致胸部和手臂的皮肤变薄，以及腿部和臀部的骨骼变弱。此外，即使您没有怀孕，您的乳房也可能会分泌乳汁。它还会导致血压的各种变化，包括脸红和手臂和腿部血压升高。

市场动态：

脑下垂体瘤发生率的增加、研发活动投资的增加以及治疗方法的技术进步预计将在预测期内推动全球脑下垂体癌市场的成长。此外，公众意识的提高也增加了对非侵入性治疗的需求。提供脑下垂体瘤专业服务的医院和诊所数量的增加也推动了市场的发展。

然而，癌症治疗的高成本是预计在预测期内抑制全球脑下垂体癌市场成长的主要因素。

本研究的主要特点

  • 本报告详细分析了全球脑下垂体癌市场，并提供了以2022年为基准年的预测期（2023-2030）的市场规模和年复合成长率（CAGR%）。
  • 它还阐明了各个细分市场的潜在商机，并解释了该市场有吸引力的投资提案矩阵。
  • 它还提供了有关市场驱动因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的主要考察。
  • 它根据公司亮点、产品系列、主要亮点、绩效和策略等参数，介绍了全球脑下垂体癌市场的主要企业。
  • 该报告的见解将使行销人员和公司负责人能够就未来的产品发布、升级、市场扩张和行销策略做出资讯的决策。
  • 全球脑下垂体癌市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、分销商、新进业者和财务分析师。
  • 透过用于分析全球脑下垂体癌市场的各种策略矩阵，将促进相关人员的决策。

目录

第一章 研究目的与假设

  • 研究目标
  • 假设
  • 简称

第二章 市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map（COM）

第三章市场动态、法规及趋势分析

  • 市场动态
    • 促进因素
  • 发病率和盛行率增加
  • 医疗图像处理和诊断的进展
  • 加大研发力度
  • 个人化医疗需求不断成长
    • 抑制因素
  • 识别有限且诊断延迟
  • 缺乏标准化治疗指南
  • 进行性脑下垂体癌的治疗选择有限
  • 药物开发的挑战
    • 机会
  • 标靶治疗的发展
  • 联合治疗
  • 手术技术的进步
  • 新显像模式的开发
  • 影响分析
  • 主要亮点
  • 监管场景
  • 产品发布/核准
  • PEST分析
  • 波特的分析
  • 併购场景

第四章脑下垂体癌市场－冠状病毒（COVID-19）大流行的影响

  • 新型冠状病毒感染疾病（COVID-19）的流行病学
  • 供需面分析
  • 经济影响

第五章脑下垂体癌市场，依癌症类型，2018-2030

  • 介绍
  • 脑下垂体腺瘤（良性肿瘤）
  • 脑下垂体癌（恶性）

第六章脑下垂体癌市场，依荷尔蒙类型，2018-2030

  • 介绍
  • 催乳素瘤
  • 生长激素分泌肿瘤（肢端肥大症）
  • 促肾上腺皮质激素分泌肿瘤（库欣氏症）
  • 甲状腺刺激素分泌肿瘤（TSHoma）
  • 促性腺激素分泌分泌肿瘤

第 7 章 2018-2030 年脑下垂体癌市场（依治疗类型）

  • 介绍
  • 外科手术
  • 放射治疗
  • 药物治疗（例如多巴胺促效剂、生长抑素类似物、荷尔蒙替代疗法）
  • 标靶治疗
  • 化疗

第 8 章 2018-2030 年脑下垂体癌市场（依年龄层）

  • 介绍
  • 儿童
  • 成人

第 9 章 脑下垂体癌市场，依最终使用者划分，2018-2030 年

  • 介绍
  • 医院
  • 专科诊所
  • 癌症治疗中心
  • 研究机构

第10章脑下垂体癌市场，依地区，2018-2030

  • 介绍
  • 北美洲
  • 美国
  • 加拿大
  • 欧洲
  • 英国
  • 德国
  • 义大利
  • 法国
  • 西班牙
  • 俄罗斯
  • 欧洲其他地区
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • 东南亚国协
  • 澳洲
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
  • 中东和非洲
  • 海湾合作委员会国家
  • 以色列
  • 北非
  • 中部非洲
  • 中东和非洲其他地区

第十一章竞争形势

  • Novartis International AG
  • Pfizer Inc.
  • Ipsen Biopharmaceuticals, Inc.
  • Endocyte
  • RECORDATI GROUP
  • Camurus AB
  • Endeavor Biomedicines, Inc
  • Debiopharm International SA

第12章 章节

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI5851

The global pituitary cancer market size was estimated to be US$ 380.7 million in 2023 and is projected to reach US$ 723.2 million by 2030, growing at a CAGR of 9.6% during the forecast period (2023-2030).

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 380.7 Mn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 9.60% 2030 Value Projection: US$ 723.3 Mn
Figure 1. Global Pituitary Cancer Market Share (%), By Region, 2023
Pituitary Cancer Market - IMG1

The cause of pituitary cancer is not well understood. But genetics and hormonal imbalances may play a role. Most pituitary tumors are adenomas, or noncancerous. They are not as common as pituitary gland cysts, which are benign (noncancerous).

Symptoms of pituitary cancer often include headaches, vision changes, loss of weight or an inability to gain weight, and trouble with memory and concentration. Some types of pituitary tumors release too many hormones, which can lead to a disease called Cushing's syndrome. In some cases, this disease causes the body to produce too much prolactin, which can cause thinning of the skin in the chest and arms, and weak bones in the legs and feet. Other forms of this condition can cause the breasts to make milk, even when the person is not pregnant. The condition can also cause a wide range of changes in blood pressure, including a flushed face and high blood pressure in the arms or legs.

Market Dynamics:

Rising incidences of pituitary tumors, increasing investments in research and development activities, and technological advancements in treatment methods are expected to drive growth of the global pituitary cancer market during the forecast period. In addition, increased awareness among the populace has led to a higher demand for noninvasive treatments. The market is also driven by a rise in the number of hospitals and clinics that offer specialized services for pituitary tumors.

However, the high cost of cancer treatments is a major factor expected to impede the growth of the global pituitary cancer market over the forecast period.

Key features of the study:

  • This report provides in-depth analysis of the global pituitary cancer market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global pituitary cancer market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Novartis International AG, Pfizer Inc., Ipsen Biopharmaceuticals, Inc., Endocyte, RECORDATI GROUP, Camurus AB, Endeavor Biomedicines, Inc., and Debiopharm International SA
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global pituitary cancer market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pituitary cancer market

Global Pituitary Cancer Market Detailed Segmentation:

  • By Cancer Type:
    • Pituitary Adenoma (Benign Tumor)
    • Pituitary Carcinoma (Malignant Tumor)
  • By Hormone Type:
    • Prolactinoma
    • Growth Hormone-Secreting Tumor (Acromegaly)
    • Adrenocorticotropic Hormone-Secreting Tumor (Cushing's Disease)
    • Thyroid-Stimulating Hormone-Secreting Tumor (TSHoma)
    • Gonadotropin-Secreting Tumor
  • By Treatment Type:
    • Surgery
    • Radiation Therapy
    • Medications (e.g., dopamine agonists, somatostatin analogs, hormone replacement therapy)
    • Targeted Therapy
    • Chemotherapy
  • By Age Group:
    • Pediatric
    • Adult
  • By End User:
    • Hospitals
    • Specialty Clinics
    • Cancer Treatment Centers
    • Research Institutes
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa
  • Company Profile:
    • Novartis International AG
    • Pfizer Inc.
    • Ipsen Biopharmaceuticals, Inc.
    • Endocyte
    • RECORDATI GROUP
    • Camurus AB
    • Endeavor Biomedicines, Inc.
    • Debiopharm International SA

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Pituitary Cancer, By Cancer Type
    • Market Pituitary Cancer, By Hormone Type
    • Market Pituitary Cancer, By Treatment Type
    • Market Pituitary Cancer, By Age Group
    • Market Pituitary Cancer, By End User
    • Market Pituitary Cancer, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
  • Increasing Incidence and Prevalence
  • Advancements in Medical Imaging and Diagnostics
  • Increased Research and Development
  • Growing Demand for Personalized Medicine
    • Restraints
  • Limited Awareness and Delayed Diagnosis
  • Lack of Standardized Treatment Guidelines
  • Limited Treatment Options for Aggressive Pituitary Cancers
  • Challenges in Drug Development
    • Opportunities
  • Development of Targeted Therapies
  • Combination Therapies
  • Advancements in Surgical Techniques
  • Development of Novel Imaging Modalities
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Pituitary Cancer Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Pituitary Cancer Market , By Cancer Type, 2018-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Pituitary Adenoma (Benign Tumor)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
  • Pituitary Carcinoma (Malignant Tumor)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)

6. Pituitary Cancer Market , By Hormone Type, 2018-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Prolactinoma
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
  • Growth Hormone-Secreting Tumor (Acromegaly)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
  • Adrenocorticotropic Hormone-Secreting Tumor (Cushing's Disease)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
  • Thyroid-Stimulating Hormone-Secreting Tumor (TSHoma)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
  • Gonadotropin-Secreting Tumor
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)

7. Pituitary Cancer Market , By Treatment Type, 2018-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018- 2030
    • Segment Trends
  • Surgery
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
  • Radiation Therapy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
  • Medications(e.g., dopamine agonists, somatostatin analogs, hormone replacement therapy)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
  • Targeted Therapy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
  • Chemotherapy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)

8. Pituitary Cancer Market , By Age Group, 2018-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Pediatric
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
  • Adult
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)

9. Pituitary Cancer Market , By End User, 2018-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
  • Specialty Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
  • Cancer Treatment Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)
  • Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Million)

10. Pituitary Cancer Market , By Region, 2018-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Country, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Country 2018-2030
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Hormone Type, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Hormone Type, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Hormone Type, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Hormone Type, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East & Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Hormone Type, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
  • GCC
  • Israel
  • North Africa
  • Central Africa
  • Rest of Middle East & Africa

11. Competitive Landscape

  • Novartis International AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Pfizer Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Ipsen Biopharmaceuticals, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Endocyte
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • RECORDATI GROUP
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Camurus AB
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Endeavor Biomedicines, Inc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Debiopharm International SA
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

12. Section

  • Research Methodology
  • About us